|SEQ_NO||1||Date of announcement||2022/01/17||Time of announcement||16:34:59|
|Subject||Announcement of TTY Biopharm's unaudited income information in December 2021|
|Date of events||2022/01/17||To which item it meets||paragraph 53|
|Statement||1.Date of occurrence of the event:2022/01/17
2.Company name:TTY Biopharm Co., Ltd.
3.Relationship to the Company (please enter ”head office” or ”subsidiaries”):Head office
4.Reciprocal shareholding ratios:N/A
5.Cause of occurrence:TTY Biopharm posted a consolidated net sales of $473,141 thousands (expressed in NT dollars; unaudited), a consolidated operating profit of $100,008 thousands, and a consolidated income before tax of $127,721 thousands in December 2021; net income attributed to stockholders of the parent company was $110,918 thousands; EPS is $0.45.
Year-to-date consolidated net sales was $4,536,126 thousands (in NT dollars; unaudited), a consolidated operating profit was $1,139,546 thousands and consolidated income before tax was $1,084,902 thousands until December 2021; year-to-date net income attributed to stockholders of the company was $827,772 thousands; EPS is $3.33.
7.Any other matters that need to be specified:
The numbers above are unaudited. In term of the final net sales and profits, quarterly financial reports audited by independent accountants will prevail.